InsiderTrades

Form 4 for CPIX CUMBERLAND PHARMACEUTICALS INC

Accepted 2021-11-05 00:00:00 ET · period of report 2021-10-01 · accession 0001209191-21-063217 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
M 2021-11-05 2021-10-01+ CPIX Cearnal Martin E SVP, Chief Commercial Off, Dir P - Purchase $2.72 +2,205 171.8K +1% +$5,999

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2021-10-04 P A 105 $2.87 171,879 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.
2 Common Common Stock 2021-10-05 P A 105 $2.82 171,984 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.
3 Common Common Stock 2021-10-06 P A 105 $2.76 172,089 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.
4 Common Common Stock 2021-10-07 P A 105 $2.76 172,194 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.
5 Common Common Stock 2021-10-08 P A 105 $2.84 172,299 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.
6 Common Common Stock 2021-10-11 P A 105 $2.73 172,404 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.
7 Common Common Stock 2021-10-12 P A 105 $2.71 172,509 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.
8 Common Common Stock 2021-10-13 P A 105 $2.71 172,614 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.
9 Common Common Stock 2021-10-14 P A 105 $2.81 172,719 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.
10 Common Common Stock 2021-10-15 P A 105 $2.76 172,824 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.
11 Common Common Stock 2021-10-18 P A 105 $2.75 172,929 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.
12 Common Common Stock 2021-10-19 P A 105 $2.76 173,034 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.
13 Common Common Stock 2021-10-20 P A 105 $2.63 173,139 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.
14 Common Common Stock 2021-10-21 P A 105 $2.65 173,244 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.
15 Common Common Stock 2021-10-22 P A 105 $2.66 173,349 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.
16 Common Common Stock 2021-10-25 P A 105 $2.64 173,454 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.
17 Common Common Stock 2021-10-26 P A 105 $2.64 173,559 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.
18 Common Common Stock 2021-10-27 P A 105 $2.61 173,664 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.
19 Common Common Stock 2021-10-28 P A 105 $2.61 173,769 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.
20 Common Common Stock 2021-10-29 P A 105 $2.72 173,874 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.
21 Common Common Stock 2021-10-01 P A 105 $2.69 171,774 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.